secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2026-08-05T12:00:29+00:00
Accession:  0001493152-26-036104
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech terminates ATM equity distribution agreement with Maxim Group
----------------------------------------------------------------------------

- Mutual termination of Equity Distribution Agreement with Maxim Group effective August 15, 2026; no penalties incurred.
- From April 2025 to July 2026, sold 3,200,736 shares for aggregate gross proceeds of approximately $2.8 million.
- No additional shares will be sold under the agreement prior to termination; company may seek alternative financing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315226036104/0001493152-26-036104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315226036104/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer